| Date Filed | Type | Description |
| 03/03/2023 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,663 shares
@ $0
Granted 22,000 shares
@ $0
Sold 1,968 shares
@ $45.27, valued at
$89.1k
Disposed/sold 3,394 shares
@ $45.65, valued at
$154.9k
Granted 39,400 options to buy
@ $45.65, valued at
$1.8M
|
|
| 03/15/2022 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 10,281 shares
@ $67.01, valued at
$688.9k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
5
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 5 on Ultragenyx Pharmaceutical Inc. |
| 10/18/2021 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 286 shares
@ $81.14, valued at
$23.2k
|
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2020 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 348 shares
@ $69.38, valued at
$24.1k
|
|
| 05/08/2020 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 248 shares
@ $66.26, valued at
$16.4k
|
|
| 04/21/2020 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 248 shares
@ $58.57, valued at
$14.5k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2019 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,434 shares
@ $0 |
|
| 06/04/2019 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 346 shares
@ $54.93, valued at
$19k
|
|
| 05/22/2019 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 381 shares
@ $59.5, valued at
$22.7k
|
|
| 05/07/2019 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,434 shares
@ $0 |
|
| 04/23/2019 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 248 shares
@ $64.43, valued at
$16k
|
|
| 04/17/2019 |
4/A
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 7,000 shares
@ $0
Sold 832 shares
@ $65.52, valued at
$54.5k
Granted 21,500 options to buy
@ $67.55, valued at
$1.5M
|
|
| 03/04/2019 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 7,000 shares
@ $0
Paid exercise price by delivering 806 shares
@ $67.55, valued at
$54.4k
Granted 21,500 options to buy
@ $67.55, valued at
$1.5M
|
|
| 06/04/2018 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 346 shares
@ $73.73, valued at
$25.5k
|
|
| 05/22/2018 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 381 shares
@ $64.79, valued at
$24.7k
|
|
| 04/19/2018 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,431 shares
@ $0 |
|
| 03/05/2018 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 6,000 shares
@ $0
Paid exercise price by delivering 307 shares
@ $48.43, valued at
$14.9k
Granted 30,000 options to buy
@ $48.43, valued at
$1.5M
|
|
| 06/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |